ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,896Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 54

$638K Total Retail Price of All Prescriptions

Rank: 7 out of 54

410 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

6% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 457 429 1 2
SIMVASTATIN 326 299 2 5
FUROSEMIDE 264 260 3 3
DONEPEZIL HCL 253 253 4 8
LISINOPRIL 243 221 5 6
METOPROLOL TARTRATE 229 225 6 7
AMLODIPINE BESYLATE 188 162 7 4
METOPROLOL SUCCINATE 174 151 8 14
CITALOPRAM HBR 159 159 9 17
ATORVASTATIN CALCIUM 154 131 10 15
SERTRALINE HCL 150 136 11 12
WARFARIN SODIUM 126 126 12 1
NAMENDA 120 120 13 13
MIRTAZAPINE 117 114 14 11
ATENOLOL 110 107 15 24
ESCITALOPRAM OXALATE 109 100 16 18
METFORMIN HCL 105 85 17 19
TRAZODONE HCL 102 94 18 10
HYDRALAZINE HCL 102 99 18 58
LANTUS 93 78 20 30
ALENDRONATE SODIUM 92 83 21 31
TRAMADOL HCL 90 61 22 32
PREDNISONE 90 74 22 34
OMEPRAZOLE 89 77 24 9
RISPERIDONE 85 81 25 23
DIOVAN 82 78 26 29
HYDROCHLOROTHIAZIDE 81 81 27 20
AZITHROMYCIN 74 69 28 65
DIGOXIN 74 74 28 40
GABAPENTIN 73 52 30 16
LOSARTAN POTASSIUM 70 70 31 48
HYDROCODONE-ACETAMINOPHEN 70 55 S3 31 39
PANTOPRAZOLE SODIUM 67 58 33 33
CLOPIDOGREL 67 63 33 38
ZOLPIDEM TARTRATE 67 57 33 35
FAMOTIDINE 66 62 36 55
PRAVASTATIN SODIUM 66 51 36 27
ISOSORBIDE MONONITRATE ER 65 65 38 41
CHLORTHALIDONE 64 62 39 112
TAMSULOSIN HCL 62 62 40 25
LEXAPRO 58 55 41 60
LIDODERM 57 51 42 44
OXYBUTYNIN CHLORIDE ER 57 49 42 62
CARVEDILOL 55 55 44 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.